Drs Indu Subramanian and Kathrin LaFaver discuss some of their highlights from the International Congress of Parkinson's Disease and Movement Disorders (MDS) 2024.
Clinical Professor, Department of Neurology, University of California Los Angeles; PADRECC Director, West Los Angeles Veterans Association, Los Angeles, CaliforniaKathrin LaFaver, MDand Movement Disorder s that just happened in Philadelphia. I am Dr Indu Subramanian. I'm based in Los Angeles. We're just back from the meeting in Philadelphia. I didn't go last year, so it was really nice to see everyone in person.
I believe that some of the palliative care principles that Janis talks about can be brought in from diagnosis and understanding who the person is, what brings them value and meaning in life, purpose, and preserving that identity throughout their disease time course into their later years. Dr Abhimanyu Mahajan from University of Cincinnati argued that no, we are not quite there yet. The audience response sided largely with him. Dr Mahajan made many good arguments for why there are things that clinicians — or humans — bring to the table, and he made it very entertaining.
In the end, the conclusions were that we matter, the patient matters, and our rapport and connection with the patient and their family is really at the core of what we do and why we do this.I was really excited to see this in the plenary because I think we haven't had this type of content before.
Hopefully we'll see some sort of response from the MDS moving forward. As Parkinson's disease doctors, I think we're more acting as advocates, which I'm really excited to see; we're not just passive recipients of knowledge at this forum who are then going back to our clinics and doing the same old thing.As part of that same plenary, there was also a session on infection and Parkinson's.
Parkinson Disease Parkinsons Parkinson Parkinson Disease (PD) Movement Disorder Alzheimer's Disease Alzheimer Disease Artificial Intelligence Deep Learning AI NPL Machine Learning ML Natural Language Processing Artificial Neural Networks Healthcare And Medical Technology Health And Medical Tech Health And Med Tech Health And Medical Technology
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
FDA Approves New Treatment for Advanced Parkinson’s DiseaseThe FDA has just approved a new injectable treatment for adults with advanced Parkinson’s disease called Vyalev (also known as Produodopa).
Read more »
Air Pollution Exposure and Risk for Parkinson's Disease and Dyskinesia: New DataIncreased exposure to nitrogen dioxide and particulate matter in the air was associated with an increased risk for Parkinson's disease and dyskinesia.
Read more »
TEMPO Trials: Tavapadon Marches on in Parkinson's DiseaseThe experimental oral partial dopamine receptor agonist racked up positive results without a new safety signal in two phase 3 trials.
Read more »
Parkinson's Disease Linked to ADHD in Large Brain StudyParkinson's disease and ADHD are genetically linked, finds a brain study that could provide a roadmap for future treatment.
Read more »
Closing in on Parkinson's Disease proteins in extracellular vesicles in the bloodBrain disorders like Parkinson's or Alzheimer's Disease start to develop in patients much earlier than when their first clinical symptoms appear. Treating patients at these early stages could slow or even stop their disease, but there is currently no way to diagnose brain disorders at those pre-symptomatic stages.
Read more »
Recreating a hallmark of Parkinson's disease in human neuronsScientists have recreated the growth of Lewy bodies in human neurons and followed their formation to gain important insight into why and how they form. Critically, they find that immune challenge is important for this process, identifying a previously unknown link between the immune system and neurological disease.
Read more »